Addus HomeCare Net Worth 2010-2025 | ADUS

Interactive chart of historical net worth (market cap) for Addus HomeCare (ADUS) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Addus HomeCare net worth as of August 29, 2025 is $2.12B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.123B $1.155B
ADDUS HOMECARE is a comprehensive provider of a broad range of social and medical services in the home. The company's services include personal care and assistance with activities of daily living, skilled nursing and rehabilitative therapies, and adult day care. Its consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its payor clients include federal, state and local governmental agencies, the Veterans Health Administration, commercial insurers and private individuals. Addus operates its business through two divisions, home & community services and home health services. The home & community services are social, or non-medical, in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living whereas the home health services are medical in nature and include physical, occupational and speech therapy, as well as skilled nursing.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.312B 19.41
Encompass Health (EHC) United States $12.264B 24.50
DaVita (DVA) United States $9.850B 14.09
Elanco Animal Health (ELAN) United States $9.117B 20.39
Chemed (CHE) United States $6.673B 22.35
RadNet (RDNT) United States $5.520B 199.33
Option Care Health (OPCH) United States $4.655B 19.92
LifeStance Health (LFST) United States $2.131B 0.00
Astrana Health (ASTH) United States $1.792B 62.67
Aveanna Healthcare Holdings (AVAH) United States $1.671B 30.77
U.S Physical Therapy (USPH) United States $1.260B 31.52
Atai Life Sciences (ATAI) Germany $0.982B 0.00
Pennant (PNTG) United States $0.830B 29.28
Daxor (DXR) United States $0.053B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.051B 0.00
Psychemedics (PMD) United States $0.000B 0.00